XTuit Pharmaceuticals

About:

XTuit Pharmaceuticals develops pharmaceutical preparations for the diagnosis and treatment of oncological, tumor, and inflammatory diseases.

Website: http://xtuit.com

Top Investors: Polaris Partners, New Enterprise Associates, Omega Funds, CTI Life Sciences Fund, Arcus Ventures

Description:

XTuit Pharmaceuticals develops pharmaceutical preparations for use in the diagnosis and treatment of oncological, tumor, and inflammatory diseases. The company is pursuing novel approaches to improving cancer therapy by targeting the tumor microenvironment. It was incorporated in 2011 and is based in Waltham, Massachusetts.

Total Funding Amount:

$26M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)xtuit.com

Founders:

Rakesh K. Jain

Number of Employees:

11-50

Last Funding Date:

2015-06-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai